The presence of ADMA-independent effects of DDAH1 is also supported by the observation that overexpression of the active site mutant of DDAH1 was able to affect the growth of glioma xenografts, while the total DDAH activity in the lysates of tumor cells remained unchanged [69]. Here, DDAH1 is linked to central nervous system cancer.